Global Metered Dose Inhalers Market
The Global Metered Dose Inhalers Market was valued at US$ 24,210 Million in 2021 and would rocket up to US$ 35,120 Million by 2027 at a CARG 3.2% from 2022-2027.
Metered Dose Inhalers (MDI) is a pressurized inhaler which delivers medication by using a propellent spray. It is broadly useful for people with respiratory disorders like Chronic Obstructive Pulmonary disease, Asthma, Chronic Bronchitis, Emphysema.
Metered Dose Inhalers (MDI) is a system of Aerosol Delivery. The crucial advantage of aerosol drug delivery is quick onset of therapeutic action as the drug is delivered to the target site of action. These Inhalers delivers fixed quantity of drug to the lungs in the form of aerosolized drug to provide to impart quick pharmacological action.
Market Drivers
Rise in incidence of respiratory disease such as asthma, chronic obstructive pulmonary diseases, chronic respiratory diseases, and other respiratory disease are driving the market of Metered Dose Inhalers. Additionally, there is an increased awareness of efficacious and developed respiratory instruments compared to conventional treatments boost the market of Metered Dose Inhalers. The technological improvement by respiratory device manufacturers have augment the growth of Metered Dose Inhalers Market.
Metered Dose Inhaler are convenient to use and have several benefits such as being potable, multidose delivery capacity, easy to use, giving fast relief, and free from bacterial contamination as it is prefilled. The above listed components also dive the sales of Metered Dose Inhaler.
Market Restraints
The elements that restraint the growth of Metered Dose Inhaler are high cost of medication and device, lack of awareness between the people regarding advanced treatment and available devices for respiratory diseases and turn down the investment in research and development activities. The manufacturing cost of metered dose inhaler is high and they may have reaction of the medication to be inhaled, which is expected to hamper the market of Metered Dose Inhalers.
Market Segmentation
The Global Metered Dose Inhalers (MDI) Market is segmented into Product Type, Application, Distribution Channel. By Product Type such as Manually Actuated Pressurised Inhaler, Breath Actuated Pressurised inhaler. By Application such as Chronic Obstructive Pulmonary disease, Asthma, Chronic Bronchitis, Emphysema. By Distribution Channel such as Retail Pharmacies, Hospital Pharmacies, E-Commerce.
Regional Analysis
The Global Metered Dose Inhalers (MDI) Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Asia Pacific shows the vast opportunity for market growth owing to the rising incidence of asthma that has occur due to high level of sir pollution, rapid urbanization, the growing smoking population and changing lifestyle. At present, North America combined with Asia Pacific Region is expected to hold the huge market share and influence the overall metered dose market owing to increase in research and development activities, rising awareness about hi-tech respiratory devices and growing prevalence of respiratory disorder in this region. North America is responsible 41.1% of the global market share of metered dose market, with Europe at 27.4% of the total market size of metered dose inhalers.
Key Players
Various Key Players are listed in this report such as Midascare Pharmaceuticals Pvt. Ltd., Beximco Pharma Ltd., GlaxoSmithKline Pharmaceuticals Ltd., 3M Pharmaceuticals Pty Ltd., Biocare Manufacturing Sdn Bhd., Anomatic Innovation & Design Center & Manufacturing, Aristo Pharma Ltd.
Intech Biopharm Corporation, Swiss Pharmaceuticals Pvt. Ltd.
Market Taxonomy
By Product Type
By Application
By Distribution Channel
By Region
Global Metered Dose Inhalers Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Metered Dose Inhalers Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Metered Dose Inhalers Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Metered Dose Inhalers Market Share Analysis, By Product Type
5.3 Global Metered Dose Inhalers Market Size and Forecast, By Product Type
5.3.1 Manually Actuated Pressurized Inhaler
5.3.2 Breath Actuated Pressurized inhaler.
6 Global Metered Dose Inhalers Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Metered Dose Inhalers Market Share Analysis, By Application
6.3 Global Metered Dose Inhalers Market Size and Forecast, By Application
6.3.1 Chronic Obstructive Pulmonary disease
6.3.2 Asthma
6.3.3 Chronic Bronchitis
6.3.4 Emphysema
7 Global Metered Dose Inhalers Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Metered Dose Inhalers Market Share Analysis, By Distribution Channel
7.3 Global Metered Dose Inhalers Market Size and Forecast, By Distribution Channel
7.3.1 Retail Pharmacies
7.3.2 Hospital Pharmacies
7.3.3 E-Commerce.
8 Global Metered Dose Inhalers Market, By Region
8.1 Global Metered Dose Inhalers Market Share Analysis, By Region
8.2 Global Metered Dose Inhalers Market Share Analysis, By Region
8.3 Global Metered Dose Inhalers Market Size and Forecast, By Region
9 North America Metered Dose Inhalers Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Metered Dose Inhalers Market Share Analysis, By Product Type
9.3 North America Metered Dose Inhalers Market Size and Forecast, By Distribution Channel
9.4 North America Metered Dose Inhalers Market Size and Forecast, By Application
9.5 North America Metered Dose Inhalers Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Metered Dose Inhalers Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Metered Dose Inhalers Market Share Analysis, By Product Type
10.3 Europe Metered Dose Inhalers Market Size and Forecast, By Distribution Channel
10.4 Europe Metered Dose Inhalers Market Size and Forecast, By Application
10.5 Europe Metered Dose Inhalers Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific Metered Dose Inhalers Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Metered Dose Inhalers Market Share Analysis, By Product Type
11.3 Asia Pacific Metered Dose Inhalers Market Size and Forecast, By Distribution Channel
11.4 Asia Pacific Metered Dose Inhalers Market Size and Forecast, By Application
11.5 Asia Pacific Metered Dose Inhalers Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Metered Dose Inhalers Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Metered Dose Inhalers Market Share Analysis, Product Type
12.3 Latin America Metered Dose Inhalers Market Size and Forecast, By Distribution Channel
12.4 Latin America Metered Dose Inhalers Market Size and Forecast, By Application
12.5 Latin America Metered Dose Inhalers Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Metered Dose Inhalers Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Metered Dose Inhalers Market Share Analysis, By Product Type
13.3 Middle East Metered Dose Inhalers Market Size and Forecast, By Distribution Channel
13.4 Middle East Metered Dose Inhalers Market Size and Forecast, By Application
13.5 Middle East Metered Dose Inhalers Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Midascare Pharmaceuticals Pvt. Ltd
15.1.1 Overview
15.1.2 Products
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Beximco Pharma Ltd.
15.2.1 Overview
15.2.2 Products
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
12.2.6 Key Strategies
15.3. GlaxoSmithKline Pharmaceuticals Ltd
15.3.1 Overview
15.3.2 Products
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 3M Pharmaceuticals Pty Ltd
15.4.1 Overview
15.4.2 Products
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Biocare Manufacturing Sdn Bhd.
15.5.1 Overview
15.5.2 Products
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Anomatic Innovation & Design Center & Manufacturing
15.6.1 Overview
15.6.2 Products
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Aristo Pharma Ltd.
15.7.1 Overview
15.7.2 Products
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Swiss Pharmaceuticals Pvt. Ltd.
15.8.1 Overview
15.8.2 Products
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
